MapLight said the twice-daily dose met the primary endpoint of the schizophrenia trial, but the daily dose did not.
If Andembry reaches the paediatric HAE market, it would have to contend with the best-seller Takhzyro and new oral option Orladeyo.
There are no approved pharmacological treatments for biliary atresia, which is the leading cause of paediatric liver transplant.
China is rapidly overtaking the US in global oncology clinical trials, accounting for more than half of late-stage study activity by 2025.
Two of J&J’s BiTE therapies, Tecvayli and Talvey, have demonstrated their combinatory potential in relapsed/refractory multiple myeloma. Credit: David A Litman / Shutterstock.com. Johnson & Johnson (J ...
Eli Lilly is set for another win in the glucagon-like peptide-1 (GLP-1) sector as its triple-g agonist, retatrutide, has succeeded in type 2 diabetes and obesity. Marking the four ...
Participants in SHASTA-3 and SHASTA-4 received 25mg of plozasiran via subcutaneous injection every three months. Credit: YURIMA / Shutterstock.com. Arrowhead Pharmaceuticals has reported top line ...
The funds will help Crystalys progress its clinical-stage development efforts and commercialisation plans for its gout drug, dotinurad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results